0001078782-15-000290.txt : 20150223 0001078782-15-000290.hdr.sgml : 20150223 20150223112655 ACCESSION NUMBER: 0001078782-15-000290 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150223 DATE AS OF CHANGE: 20150223 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Rich Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001504389 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463259117 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-86921 FILM NUMBER: 15638600 BUSINESS ADDRESS: STREET 1: 9595 WILSHIRE BLVD., SUITE 900 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 BUSINESS PHONE: (424) 230-7001 MAIL ADDRESS: STREET 1: 9595 WILSHIRE BLVD., SUITE 900 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 FORMER COMPANY: FORMER CONFORMED NAME: Nepia Inc. DATE OF NAME CHANGE: 20101027 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Vista Capital Investments, LLC CENTRAL INDEX KEY: 0001616977 IRS NUMBER: 274439472 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 4342 VISTA WAY CITY: LA MESA STATE: CA ZIP: 91941 BUSINESS PHONE: (619) 543-0328 MAIL ADDRESS: STREET 1: 4342 VISTA WAY CITY: LA MESA STATE: CA ZIP: 91941 SC 13G 1 sc13g022015_sc13g.htm SCHEDULE 13G SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


SCHEDULE 13G


Under the Securities Exchange Act of 1934


Rich Pharmaceuticals, Inc.

(Name of issuer)

 

Common Stock, $0.001 value per share

(Title of class of securities)

 

76303T209

(CUSIP number)

 

February 11, 2015

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


      .Rule 13d-1(b)


  X .Rule 13d-1(c)


      .Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




CUSIP No . 76303T209

13G

Page 2 of 6 Pages


1

NAME OF REPORTING PERSON

 

 

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

 

 

 

 

VISTA CAPITAL INVESTMENTS, LLC.

 

 

EIN: 27-4439472

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)      .

 

 

(b)  X .

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

 

 

 

California

 

 

5

SOLE VOTING POWER

 

 

 

 

 

 

 

0

 

NUMBER OF

6

SHARED VOTING POWER

 

SHARES

 

 

 

BENEFICIALLY

 

74,750,00

 

OWNED BY EACH

7

SOLE DISPOSITIVE POWER

 

REPORTING

 

 

 

PERSON WITH

 

0

 

 

8

SHARED DISPOSITIVE POWER

 

 

 

 

 

 

 

74,750,00

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

 

 

74,750,00

 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*      .

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

 

 

 

 

9.9%

 

12

TYPE OF REPORTING PERSON*

 

 

 

 

 

OO- Limited Liability Company

 






CUSIP No . 76303T209

13G

Page 3 of 6 Pages


1

NAME OF REPORTING PERSON

 

 

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

 

 

 

 

David Clark

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)      .

 

 

(b)  X .

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

 

 

 

United States

 

 

5

SOLE VOTING POWER

 

 

 

 

 

 

 

0

 

NUMBER OF

6

SHARED VOTING POWER

 

SHARES

 

 

 

BENEFICIALLY

 

74,750,00

 

OWNED BY EACH

7

SOLE DISPOSITIVE POWER

 

REPORTING

 

 

 

PERSON WITH

 

0

 

 

8

SHARED DISPOSITIVE POWER

 

 

 

 

 

 

 

74,750,00

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

 

 

74,750,00

 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*      .

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

 

 

 

 

9.9%

 

12

TYPE OF REPORTING PERSON*

 

 

 

 

 

IN

 




CUSIP No . 76303T209

13G

Page 4 of 6 Pages


Item 1

(a)

Name of Issuer:


Rich Pharmaceuticals, Inc., a Nevada corporation


(b)

Address Of Issuer's Principal Executive Offices:


9595 Wilshire Blvd, Suite 900

Beverly Hills, CA 90212


Item 2

(a)

Name of Person Filing:


VISTA CAPITAL INVESTMENTS, LLC

David Clark


All of the securities covered by this report are owned directly by Vista Capital Investments, LLC. David Clark is a member and principal of Vista Capital Investments, LLC. As permitted by Rule 13d-4, the filing of this statement shall not be construed as an admission that David Clark is the beneficial owner of any of the securities covered by this statement, and David Clark expressly disclaims any equitable or beneficial ownership of such securities.


(b)

Address of Principal Business Office, or, if none, Residence:


Address for all filers:  402 West Broadway, San Diego, California 92101


(c)

Citizenship:


Vista Capital Investments, LLC was formed under the laws of the State of California.

David Clark is a United States citizen.


(d)

Title of Class of Securities:


Common Stock, $0.001 value per share


(e)

Cusip Number:


76303T209


Item 3

If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


Not Applicable




CUSIP No . 76303T209

13G

Page 5 of 6 Pages


Item 4

Ownership


(a)

Amount beneficially owned: 74,750,000*


(b)

Percent of class:  9.9%*


(c)

Number of shares as to which the person has:


(i)

Sole power to vote or to direct the vote: 0


(ii)

Shared power to vote or to direct the vote: 74,750,000


(iii)

Sole power to dispose or to direct the disposition of: 0


(iv)

Shared power to dispose or to direct the disposition of:  74,750,000


* Reporting Person has rights under a convertible note to own an aggregate number of shares of the issuer common stock not to exceed 9.9 percent of shares outstanding. The Reporting Persons’ beneficial ownership of 74,750,000 shares of Common Stock constitutes 9.9% of all the outstanding shares of Common Stock, based upon a total of 748,618,351shares of Common Stock.


Item 5

Ownership of Five Percent or Less of a Class


If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.


Item 6

Ownership of More Than Five Percent on Behalf Of Another Person


Not Applicable


Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company


Not Applicable


Item 8

Identification and Classification of Members of The Group


Not Applicable


Item 9

Notice of Dissolution of Group


Not Applicable


Item 10

Certification


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.




CUSIP No . 76303T209

13G

Page 6 of 6 Pages


SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 

VISTA CAPITAL INVESTMENTS, LLC.

 

 

 

By: 

/s/ David Clark

 

Name:

David Clark

 

Title:

Member and Principal

 

 

 

 

 

/s/ David Clark

 

 

David Clark


The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.


Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)